JM, W., JL, D., HR, Q., CL, I., HS, C., KL, D., . . . MA, B. (2026). Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 22(4), e71391. https://doi.org/10.1002/alz.71391
Chicago Style (17th ed.) CitationJM, Wilson, et al. "Dulaglutide and Neurodegeneration Biomarkers: REWIND Post Hoc Analysis." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 22, no. 4 (2026): e71391. https://doi.org/10.1002/alz.71391.
MLA (9th ed.) CitationJM, Wilson, et al. "Dulaglutide and Neurodegeneration Biomarkers: REWIND Post Hoc Analysis." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 22, no. 4, 2026, p. e71391, https://doi.org/10.1002/alz.71391.
Warning: These citations may not always be 100% accurate.
